| 1 |
30797153 | Decitabine enhances tumor recognition by T cells through upregulating the MAGE-A3 expression in esophageal carcinoma. | 2019 Apr |
2 |
| 2 |
28337274 | Decitabine treatment sensitizes tumor cells to T-cell-mediated cytotoxicity in patients with myelodysplastic syndromes. | 2017 |
2 |
| 3 |
26883197 | Induction of cancer testis antigen expression in circulating acute myeloid leukemia blasts following hypomethylating agent monotherapy. | 2016 Mar 15 |
1 |
| 4 |
23266925 | Complete remission following decitabine/dendritic cell vaccine for relapsed neuroblastoma. | 2013 Jan |
1 |
| 5 |
21626030 | MAGE-A1, MAGE-A3, and NY-ESO-1 can be upregulated on neuroblastoma cells to facilitate cytotoxic T lymphocyte-mediated tumor cell killing. | 2011 Sep |
4 |
| 6 |
19610063 | Quantitative expression and immunogenicity of MAGE-3 and -6 in upper aerodigestive tract cancer. | 2009 Oct 15 |
4 |
| 7 |
15604288 | Intratumor heterogeneity of cancer/testis antigens expression in human cutaneous melanoma is methylation-regulated and functionally reverted by 5-aza-2'-deoxycytidine. | 2004 Dec 15 |
1 |
| 8 |
11924907 | Promoter methylation controls the expression of MAGE2, 3 and 4 genes in human cutaneous melanoma. | 2002 Jan-Feb |
2 |
| 9 |
12123095 | Expression spectrum and methylation-dependent regulation of melanoma antigen-encoding gene family members in pancreatic cancer cells. | 2002 |
1 |
| 10 |
11216765 | Induction of MAGE-3 expression in lung and esophageal cancer cells. | 2001 Jan |
3 |
| 11 |
9209667 | Expression of MAGE and BAGE genes in Japanese breast cancers. | 1997 Apr |
1 |